Snakebite deal extended

A partnership involving CSL Seqirus that has saved more than 2,000 lives through access to antivenoms in Papua New Guinea (PNG) over the past six years has been extended out until 2027.

To see the whole article please log in.

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Retype password

Not a member? Sign up here